| Sanofi-Aventis (Suisse) SA - Praluent 300 mg, solution injectable en stylo prérempli |
| 65882 | | 03 | | Praluent 300 mg | | solution injectable en stylo prérempli | | C10AX14 | | Alirocumab | | 18.11.2025 | | |
|
| Composition |
| alirocumabum 300 mg, histidini hydrochloridum monohydricum, histidinum, saccharum, polysorbatum 20, aqua ad iniectabile ad solutionem pro 2 ml. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | Active Agent | Dose |
|---|
| Alirocumabum | 300mg / 2ml |
| | | | Inactive agents |
|---|
| Histidin Hydrochloride Monohydrate | | Histidine | | Polysorbatum 20 | | Saccharum |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 011 | | | | B | | Yes |
|
